All research
Oxytocin 2021-02-08 ClinicalTrials

I-ACE training trial aims to reduce professional caregiver burnout in dementia through body-emotional literacy

Integration Between Learning, Body and Emotions (I-ACE)

Background

Caregiving for individuals with dementia (PWD) is profoundly challenging, leading to high rates of burnout and reduced well-being among professional caregivers in nursing homes. Traditional non-pharmacological therapies (NPT) often focus on PWD, but caregiver support is crucial for quality of care. The current standard of care frequently overlooks the emotional and bodily aspects of the caregiver-PWD relationship, contributing to stress and compassion fatigue. This trial addresses this gap by exploring how enhanced emotional-behavioral reading of body language and self-other emotional recognition can mitigate caregiver burnout and foster a more empathetic care environment.

Study Design

This clinical trial will evaluate the Integration Between Learning, Body and Emotions (I-ACE) training program. Professional caregivers will participate in twenty-two sessions: two theoretical meetings on dementia and NPT, ten supervision meetings discussing NPT implementation cases, and ten meetings exploring bodily aspects of the relationship through theatrical exercises. Cases will be re-discussed using a body-emotional approach. Researchers will compare the I-ACE group against an active control group and a usual care control group. Primary endpoints include professional caregiver burnout, ability to understand PWD emotions, salivary oxytocin levels, sense of competence, ethical workplace climate, and perceived resident quality of life.

Results

As a clinical trial protocol, this study has not yet reported findings; instead, it outlines the intended measurements and hypotheses. The primary aim is to determine if I-ACE training reduces professional caregiver burnout. Secondary outcomes include assessing improvements in caregivers' ability to understand and respond to the emotions of PWD, particularly from eye signals. The trial also hypothesizes an increase in salivary oxytocin levels, indicating enhanced predisposition to relationship building.

The study will measure changes in caregivers' sense of competence, the ethical climate within the workplace, and the team's perception of the resident's quality of life. These metrics will be compared across the I-ACE group, an active control, and a usual care control to establish the training's efficacy in fostering a more supportive and emotionally intelligent care environment for both caregivers and PWD.

Key Findings

  • I-ACE training aims to reduce professional caregiver burnout in dementia care.
  • The program seeks to improve caregivers' emotional understanding and responsiveness to people with dementia.
  • Salivary oxytocin levels will be measured as an indicator of relationship predisposition.
  • Caregiver competence, ethical workplace climate, and resident quality of life are key outcome measures.

Why It Matters

This trial could significantly impact the well-being of professional caregivers and, by extension, the quality of life for people with dementia in nursing homes. If successful, I-ACE training offers a novel, non-pharmacological strategy to combat caregiver burnout, a pervasive issue in long-term care. Implementing this training could lead to more empathetic, competent, and resilient care teams, improving the overall care environment. The focus on body language and emotional recognition provides a practical, skill-based approach that could be integrated into existing caregiver training protocols. This could shift the paradigm from purely task-oriented care to one that prioritizes emotional connection and mutual understanding, potentially reducing staff turnover and enhancing job satisfaction.


dementia caregiver-burnout non-pharmacological-therapy clinical-trial nursing-home emotional-intelligence
Source: clinicaltrials:NCT05710523 · Ingested 2026-06-16 · Digest: gemini-2.5-flash